Monday, 12 October, 2026
Heart of the Matter: SMT Targets Pre-IPO Boost Ahead of Public Debut
By TechShots Studio
Cardiovascular device maker Sahajanand Medical Technologies (SMT) is in talks to raise ₹175–200 crore in a pre-IPO funding round. Backed by key investors like Samara Capital, Morgan Stanley, and Kotak, the company is eyeing a ₹3,500 crore valuation as it gears up for its upcoming initial public offering.
Read full story at LIVEMINT